Velasco, Shirla C.

HRN: 21-24-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/05/2026
AMPICILLIN 1GM (VIAL)
04/05/2026
04/11/2026
IVT
2GMS
Q6
Prom X 11 Hours
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: